Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Breast Cancer

Free Subscription Articles published in JAMA Retrieve available abstracts of 45 articles: HTML format Text format

Single Articles

June 2018
1. PLEVRITIS SK, Berry DA, Mandelblatt JS
   Contributions of Screening and Treatment to Mortality From Breast Cancer-Reply.
   JAMA. 2018;319:2336.
   PubMed     Text format    
   
   
   
2. CHEN HH
   Contributions of Screening and Treatment to Mortality From Breast Cancer.
   JAMA. 2018;319:2335-2336.
   PubMed     Text format    
   
   
   May 2018
3. KEATING NL, Pace LE
   Breast Cancer Screening in 2018: Time for Shared Decision Making.
   JAMA. 2018;319:1814-1815.
   PubMed     Text format    
   
   
   April 2018
4. BEJNORDI BE, Litjens G, van der Laak JA
   Machine Learning Compared With Pathologist Assessment-Reply.
   JAMA. 2018;319:1726.
   PubMed     Text format    
   
   
   
5. VAN SMEDEN M, Van Calster B, Groenwold RHH
   Machine Learning Compared With Pathologist Assessment.
   JAMA. 2018;319:1725-1726.
   PubMed     Text format    
   
   
   March 2018
6. KATZ SJ, Jagsi R, Morrow M
   Reducing Overtreatment of Cancer With Precision Medicine: Just What the Doctor Ordered.
   JAMA. 2018;319:1091-1092.
   PubMed     Text format    
   
   
   February 2018
7. PEACHMAN RR
   Weighing the Risks and Benefits of Hormonal Contraception.
   JAMA. 2018 Feb 28. pii: 2673941. doi: 10.1001/jama.2018.0448.
   PubMed     Text format    
   
   
   
8. HENNEMAN JR
   In Shadow and Light-Images of Transformation Through Breast Cancer.
   JAMA. 2018;319:532-534.
   PubMed     Text format    
   
   
   January 2018
9. BALLMAN KV, McCall LM, Giuliano AE
   Axillary vs Sentinel Lymph Node Dissection in Women With Invasive Breast Cancer-Reply.
   JAMA. 2018;319:306-307.
   PubMed     Text format    
   
   
   
10. UNO H, Hassett MJ, Wei LJ
    Axillary vs Sentinel Lymph Node Dissection in Women With Invasive Breast Cancer.
    JAMA. 2018;319:306.
    PubMed     Text format    
    
    
    
11. PLEVRITIS SK, Munoz D, Kurian AW, Stout NK, et al
    Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012.
    JAMA. 2018;319:154-164.
    PubMed     Text format     Abstract available
    
    
    
12. MANSON JE, Aragaki AK, Rossouw JE
    Menopausal Estrogen Therapy and Breast Cancer Mortality-Reply.
    JAMA. 2018;319:193-194.
    PubMed     Text format    
    
    
    
13. HICKEY M, McNamara HC, Mishra GD
    Menopausal Estrogen Therapy and Breast Cancer Mortality.
    JAMA. 2018;319:193.
    PubMed     Text format    
    
    
    December 2017
14. EHTESHAMI BEJNORDI B, Veta M, Johannes van Diest P, van Ginneken B, et al
    Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer.
    JAMA. 2017;318:2199-2210.
    PubMed     Text format     Abstract available
    
    
    
15. GOLDEN JA
    Deep Learning Algorithms for Detection of Lymph Node Metastases From Breast Cancer: Helping Artificial Intelligence Be Seen.
    JAMA. 2017;318:2184-2186.
    PubMed     Text format    
    
    
    November 2017
16. ENGELHARDT KE, Barnard C, Bilimoria KY
    Wrong-Site Surgery.
    JAMA. 2017;318:2033-2034.
    PubMed     Text format    
    
    
    
17. THOMAS R, Fysh ETH, Smith NA, Lee P, et al
    Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial.
    JAMA. 2017;318:1903-1912.
    PubMed     Text format     Abstract available
    
    
    September 2017
18. SLOMSKI A
    Low-Fat Diet Reduces Mortality After Breast Cancer.
    JAMA. 2017;318:1099.
    PubMed     Text format    
    
    
    
19. GIULIANO AE, Ballman KV, McCall L, Beitsch PD, et al
    Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
    JAMA. 2017;318:918-926.
    PubMed     Text format     Abstract available
    
    
    
20. LIVINGSTON EH, Li HC
    Breast Cancer Surgery: Less Is More.
    JAMA. 2017;318:909-911.
    PubMed     Text format    
    
    
    
21. MCNEIL M
    Menopausal Hormone Therapy: Understanding Long-term Risks and Benefits.
    JAMA. 2017;318:911-913.
    PubMed     Text format    
    
    
    August 2017
22. SLOMSKI A
    Olaparib Increased Survival in Metastatic Breast Cancer.
    JAMA. 2017;318:690.
    PubMed     Text format    
    
    
    June 2017
23. KUCHENBAECKER KB, Hopper JL, Barnes DR, Phillips KA, et al
    Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
    JAMA. 2017;317:2402-2416.
    PubMed     Text format     Abstract available
    
    
    April 2017
24. HIMELSTEIN AL, Loprinzi CL, Shapiro CL
    Zoledronic Acid Dosing Interval for Metastatic Cancer-Reply.
    JAMA. 2017;317:1478.
    PubMed     Text format    
    
    
    February 2017
25. SACKEIM MG
    Eradicating a Genetic Mutation.
    JAMA. 2017;317:809.
    PubMed     Text format    
    
    
    
26. ALLEN D
    Moving the Needle on Recovery From Breast Cancer: The Healing Role of Postmastectomy Tattoos.
    JAMA. 2017;317:672-674.
    PubMed     Text format    
    
    
    
27. RUGO HS, Klein P, Melin SA, Hurvitz SA, et al
    Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
    JAMA. 2017;317:606-614.
    PubMed     Text format     Abstract available
    
    
    
28. NANGIA J, Wang T, Osborne C, Niravath P, et al
    Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
    JAMA. 2017;317:596-605.
    PubMed     Text format     Abstract available
    
    
    
29. HERSHMAN DL
    Scalp Cooling to Prevent Chemotherapy-Induced Alopecia: The Time Has Come.
    JAMA. 2017;317:587-588.
    PubMed     Text format    
    
    
    
30. MUTH CC
    Chemotherapy and Hair Loss.
    JAMA. 2017;317:656.
    PubMed     Text format    
    
    
    
31. KURIAN AW, Griffith KA, Hamilton AS, Ward KC, et al
    Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer .
    JAMA. 2017;317:531-534.
    PubMed     Text format    
    
    
    January 2017
32. BRAGG F, Holmes MV, Iona A, Guo Y, et al
    Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China.
    JAMA. 2017;317:280-289.
    PubMed     Text format     Abstract available
    
    
    
33. HIMELSTEIN AL, Foster JC, Khatcheressian JL, Roberts JD, et al
    Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial.
    JAMA. 2017;317:48-58.
    PubMed     Text format     Abstract available
    
    
    December 2016
34. BURSTEIN HJ, Schrag D
    Biosimilar Therapy for ERBB2 (HER2)-Positive Breast Cancer: Close Enough?
    JAMA. 2016 Dec 1. doi: 10.1001/jama.2016.18979.
    PubMed     Text format    
    
    
    
35. RUGO HS, Barve A, Waller CF, Hernandez-Bronchud M, et al
    Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Randomized Clinical Trial.
    JAMA. 2016 Dec 1. doi: 10.1001/jama.2016.18305.
    PubMed     Text format     Abstract available
    
    
    November 2016
36. ABBASI J
    The Nurses' Health Study Takes Fresh Aim at Breast Cancer as It Heads Into Decade Five.
    JAMA. 2016 Nov 23. doi: 10.1001/jama.2016.15976.
    PubMed     Text format    
    
    
    
37. FOUKAKIS T, von Minckwitz G, Bengtsson NO, Brandberg Y, et al
    Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial.
    JAMA. 2016;316:1888-1896.
    PubMed     Text format     Abstract available
    
    
    October 2016
38. SLOMSKI A
    Tumor Gene Testing May Help Guide Breast Cancer Treatment Decisions.
    JAMA. 2016;316:1637.
    PubMed     Text format    
    
    
    
39. VAN DEN BELT-DUSEBOUT AW, van Leeuwen FE, Burger CW
    Breast Cancer Risk After Ovarian Stimulation for In Vitro Fertilization-Reply.
    JAMA. 2016;316:1713-1714.
    PubMed     Text format    
    
    
    
40. TOMAO F, Papa A, Tomao S
    Breast Cancer Risk After Ovarian Stimulation for In Vitro Fertilization.
    JAMA. 2016;316:1713.
    PubMed     Text format    
    
    
    July 2016
41. VAN DEN BELT-DUSEBOUT AW, Spaan M, Lambalk CB, Kortman M, et al
    Ovarian Stimulation for In Vitro Fertilization and Long-term Risk of Breast Cancer.
    JAMA. 2016;316:300-12.
    PubMed     Text format     Abstract available
    
    
    May 2016
42. CORLEY DA, Haas JS, Kobrin S
    Reducing Variation in the "Standard of Care" for Cancer Screening: Recommendations From the PROSPR Consortium.
    JAMA. 2016;315:2067-8.
    PubMed     Text format    
    
    
    
43. TAYLOR-PHILLIPS S, Wallis MG, Jenkinson D, Adekanmbi V, et al
    Effect of Using the Same vs Different Order for Second Readings of Screening Mammograms on Rates of Breast Cancer Detection: A Randomized Clinical Trial.
    JAMA. 2016;315:1956-65.
    PubMed     Text format     Abstract available
    
    
    
44. BURNSIDE ES, Sickles EA, Duffy SW
    A Pragmatic Approach to Determine Components of Optimal Screening Mammography Practice.
    JAMA. 2016;315:1951-3.
    PubMed     Text format    
    
    
    April 2016
45. KRESSIN NR, Gunn CM, Battaglia TA
    Content, Readability, and Understandability of Dense Breast Notifications by State.
    JAMA. 2016;315:1786-8.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: